A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer

International Journal of Oncology

Volumn 15, Issue 1, 1999, Pages 117-119

  Milner, Benedict J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Ovarian cancer; P21WAF1 Cip1; Polymorphism

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA; TUMOR PROTEIN;

ALLELE; ARTICLE; CARCINOMA; CHROMOSOME 6; DISEASE COURSE; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; HUMAN; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; UNITED KINGDOM;

ALLELES; CARCINOMA; CHROMOSOMES, HUMAN, PAIR 6; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SCOTLAND;

EID: 0033163066     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.1.117     Document Type: Article

References (1)

1. Eccles DM, Brett L, Lessells A, Gruber L, Lane D, Steel CM and Leonard RCF: Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br J Cancer 65: 40-44, 1992.